{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T08:38:42Z","timestamp":1758098322266,"version":"3.44.0"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10787-025-01829-4","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:53:29Z","timestamp":1755021209000},"page":"4911-4939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 in comorbid chronic diseased patients, pregnant and lactating women: pathophysiology, available drug treatment, and the most suitable protocol regimen in each group"],"prefix":"10.1007","volume":"33","author":[{"given":"Hend M.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara Y.","family":"Elkholy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara M.","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna A.","family":"Orady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba Sh.","family":"Elmetwaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend Mo.","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmeen S.","family":"Abdelrady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Elgohary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7321-8023","authenticated-orcid":false,"given":"Mohamed Kh.","family":"Elmahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"1829_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47895\/amp.v54i0.1567","volume":"54","author":"M Abat","year":"2020","unstructured":"Abat M, Larracas C, Cabaluna I (2020) Should vitamin C\/ascorbic acid infusion be used in the treatment of COVID-19. Acta Med Philipp 54:1\u201313","journal-title":"Acta Med Philipp"},{"key":"1829_CR2","first-page":"164","volume":"19","author":"N Abbaspour","year":"2014","unstructured":"Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. J Res Med Sci 19:164","journal-title":"J Res Med Sci"},{"key":"1829_CR3","doi-asserted-by":"publisher","first-page":"118054","DOI":"10.1016\/j.lfs.2020.118054","volume":"257","author":"SM Abdin","year":"2020","unstructured":"Abdin SM et al (2020) Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci 257:118054. https:\/\/doi.org\/10.1016\/j.lfs.2020.118054","journal-title":"Life Sci"},{"issue":"6","key":"1829_CR4","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s43440-020-00176-1","volume":"72","author":"A Abobaker","year":"2020","unstructured":"Abobaker A, Alzwi A, Alraied AHA (2020) Overview of the possible role of vitamin C in management of COVID-19. Pharmacol Rep 72(6):1517\u20131528. https:\/\/doi.org\/10.1007\/s43440-020-00176-1","journal-title":"Pharmacol Rep"},{"issue":"13","key":"1829_CR5","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878\u20132887. https:\/\/doi.org\/10.1182\/blood-2008-06-165845","journal-title":"Blood"},{"issue":"7","key":"1829_CR6","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1681\/ASN.2020050589","volume":"31","author":"ML Adamsick","year":"2020","unstructured":"Adamsick ML et al (2020) Remdesivir in patients with acute or chronic kidney disease and COVID-19. J Am Soc Nephrol 31(7):1384\u20131386. https:\/\/doi.org\/10.1681\/ASN.2020050589","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1829_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14302\/issn.2692-1537.ijcv-20-3652","volume":"2","author":"M Alghamdi","year":"2020","unstructured":"Alghamdi M, Aljuhani N, Afrah AL, Alzahrani S, Alotaibi R, Siddiqua S, Naitah M, Alghamdi A, Alotaibi F, AlQarni A, Al-Hariqi K (2020) Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia. Int J Coronaviruses 2(2):13\u201323","journal-title":"Int J Coronaviruses"},{"issue":"6","key":"1829_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMsr1408795","volume":"376","author":"YM Arabi","year":"2017","unstructured":"Arabi YM et al (2017) Middle East respiratory syndrome. N Engl J Med 376(6):584\u2013594","journal-title":"N Engl J Med"},{"issue":"6","key":"1829_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","volume":"197","author":"YM Arabi","year":"2018","unstructured":"Arabi YM et al (2018) Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 197(6):757\u2013767. https:\/\/doi.org\/10.1164\/rccm.201706-1172OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1829_CR10","doi-asserted-by":"publisher","DOI":"10.5812\/archcid.102938","author":"L Asadi","year":"2020","unstructured":"Asadi L et al (2020) New corona virus (COVID-19) management in pregnancy and childbirth. Arch Clin Infectt Dis. https:\/\/doi.org\/10.5812\/archcid.102938","journal-title":"Arch Clin Infectt Dis"},{"issue":"9","key":"1829_CR11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","volume":"13","author":"A Assiri","year":"2013","unstructured":"Assiri A et al (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet 13(9):752\u2013761. https:\/\/doi.org\/10.1016\/S1473-3099(13)70204-4","journal-title":"Lancet"},{"issue":"6","key":"1829_CR12","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.kint.2020.10.004","volume":"98","author":"Y Azzi","year":"2020","unstructured":"Azzi Y, Parides M, Alani O, Loarte-Campos P, Bartash R, Forest S, Colovai A, Ajaimy M, Liriano-Ward L, Pynadath C, Graham J (2020) COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int 98(6):1559\u20131567","journal-title":"Kidney Int"},{"issue":"1","key":"1829_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","volume":"465","author":"M Bader","year":"2013","unstructured":"Bader M (2013) ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin. Pflug Archiv 465(1):79\u201385. https:\/\/doi.org\/10.1007\/s00424-012-1120-0","journal-title":"Pflug Archiv"},{"key":"1829_CR14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652","author":"BJ Barnes","year":"2020","unstructured":"Barnes BJ et al (2020) Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20200652","journal-title":"J Exp Med"},{"issue":"2","key":"1829_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cphy.c110041","volume":"2","author":"DP Basile","year":"2012","unstructured":"Basile DP, Anderson MD, Sutton TA (2012) Pathophysiology of acute kidney injury. Compr Physiol 2(2):1303\u20131353. https:\/\/doi.org\/10.1002\/cphy.c110041","journal-title":"Compr Physiol"},{"key":"1829_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1771694","author":"D Battaglini","year":"2020","unstructured":"Battaglini D et al (2020) Emerging therapies for COVID-19 pneumonia. Expert Opin Investig Drugs. https:\/\/doi.org\/10.1080\/13543784.2020.1771694","journal-title":"Expert Opin Investig Drugs"},{"key":"1829_CR17","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc046","author":"SR Bauer","year":"2020","unstructured":"Bauer SR et al (2020) \u201cWhat is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19? Clevel Clin J Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc046","journal-title":"Clevel Clin J Med"},{"issue":"12","key":"1829_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41574-021-00553-7","volume":"17","author":"AZ Bauer","year":"2021","unstructured":"Bauer AZ et al (2021) Paracetamol use during pregnancy - a call for precautionary action. Nat Rev 17(12):757\u2013766. https:\/\/doi.org\/10.1038\/s41574-021-00553-7","journal-title":"Nat Rev"},{"issue":"19","key":"1829_CR19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH et al (2020) Remdesivir for the treatment of COVID-19 - final report. N Engl J Med 383(19):1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMoa2007764","journal-title":"N Engl J Med"},{"issue":"5","key":"1829_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A et al (2020) Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev 16(5):442\u2013449. https:\/\/doi.org\/10.2174\/1573399815666191024085838","journal-title":"Curr Diabetes Rev"},{"key":"1829_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","volume":"68","author":"M Bernfield","year":"1999","unstructured":"Bernfield M et al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729\u2013777. https:\/\/doi.org\/10.1146\/annurev.biochem.68.1.729","journal-title":"Annu Rev Biochem"},{"issue":"14","key":"1829_CR22","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","volume":"116","author":"D Bojkova","year":"2020","unstructured":"Bojkova D, Wagner JU, Shumliakivska M, Aslan GS, Saleem U, Hansen A, Lux\u00e1n G, G\u00fcnther S, Pham MD, Krishnan J, Harter PN (2020) SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res 116(14):2207\u20132215","journal-title":"Cardiovasc Res"},{"issue":"11","key":"1829_CR23","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig 121(11):4210\u20134221. https:\/\/doi.org\/10.1172\/JCI45161","journal-title":"J Clin Investig"},{"issue":"12","key":"1829_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345(12):861\u2013869. https:\/\/doi.org\/10.1056\/NEJMoa011161","journal-title":"N Engl J Med"},{"issue":"3","key":"1829_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q et al (2020) COVID-19: abnormal liver function tests. J Hepatol 73(3):566\u2013574. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.006","journal-title":"J Hepatol"},{"issue":"4","key":"1829_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/jcm10040715","volume":"10","author":"A Camelo-Castillo","year":"2021","unstructured":"Camelo-Castillo A, Rivera-Caravaca JM, Orenes-Pi\u00f1ero E, Ram\u00edrez-Mac\u00edas I, Rold\u00e1n V, Lip GY, Mar\u00edn F (2021) Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: a review of potential implications. J Clin Med 10(4):715","journal-title":"J Clin Med"},{"issue":"19","key":"1829_CR27","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B et al (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 382(19):1787\u20131799. https:\/\/doi.org\/10.1056\/NEJMoa2001282","journal-title":"N Engl J Med"},{"issue":"12","key":"1829_CR28","doi-asserted-by":"publisher","first-page":"e0168647","DOI":"10.1371\/journal.pone.0168647","volume":"11","author":"A Carestia","year":"2016","unstructured":"Carestia A et al (2016) NETosis before and after Hyperglycemic Control in Type 2 Diabetes Mellitus Patients. PLoS ONE 11(12):e0168647. https:\/\/doi.org\/10.1371\/journal.pone.0168647","journal-title":"PLoS ONE"},{"issue":"1","key":"1829_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13054-017-1891-y","volume":"21","author":"AC Carr","year":"2017","unstructured":"Carr AC et al (2017) Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care (Lond, Engl) 21(1):300. https:\/\/doi.org\/10.1186\/s13054-017-1891-y","journal-title":"Crit Care (Lond, Engl)"},{"key":"1829_CR30","doi-asserted-by":"crossref","unstructured":"Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J. and Cai, J., 2020. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. biorxiv, 2020-02","DOI":"10.1101\/2020.02.03.931766"},{"issue":"3","key":"1829_CR31","doi-asserted-by":"publisher","first-page":"106118","DOI":"10.1016\/j.ijantimicag.2020.106118","volume":"56","author":"R Chang","year":"2020","unstructured":"Chang R, Ng TB, Sun W-Z (2020) Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int J Antimicrob Agents 56(3):106118. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106118","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1829_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12931-022-02186-4","volume":"23","author":"X Chang","year":"2022","unstructured":"Chang X et al (2022) Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data. Respir Res 23(1):301. https:\/\/doi.org\/10.1186\/s12931-022-02186-4","journal-title":"Respir Res"},{"issue":"5","key":"1829_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/427811","volume":"191","author":"Z Chen","year":"2005","unstructured":"Chen Z et al (2005) Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 191(5):755\u2013760. https:\/\/doi.org\/10.1086\/427811","journal-title":"J Infect Dis"},{"key":"1829_CR34","doi-asserted-by":"publisher","first-page":"584956","DOI":"10.3389\/fphar.2020.584956","volume":"11","author":"P-L Chen","year":"2020","unstructured":"Chen P-L et al (2020a) A review of treatment of coronavirus disease 2019 (COVID-19): therapeutic repurposing and unmet clinical needs. Front Pharmacol 11:584956. https:\/\/doi.org\/10.3389\/fphar.2020.584956","journal-title":"Front Pharmacol"},{"key":"1829_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fped.2020.00104","volume":"8","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020b) Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr 8:104. https:\/\/doi.org\/10.3389\/fped.2020.00104","journal-title":"Front Pediatr"},{"issue":"2","key":"1829_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1021\/acsptsci.1c00022","volume":"4","author":"T Chen","year":"2021","unstructured":"Chen T et al (2021) Synergistic inhibition of SARS-CoV-2 replication using disulfiram\/ebselen and remdesivir. ACS Pharmacol Transl Sci 4(2):898\u2013907. https:\/\/doi.org\/10.1021\/acsptsci.1c00022","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"11","key":"1829_CR37","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1160\/TH17-05-0347","volume":"117","author":"L Chimenti","year":"2017","unstructured":"Chimenti L, Camprub\u00ed-Rimblas M, Guillamat-Prats R, Gomez MN, Tijero J, Blanch L, Artigas A (2017) Nebulized heparin attenuates pulmonary coagulopathy and inflammation through alveolar macrophages in a rat model of acute lung injury. Thromb Haemost 117(11):2125\u20132134","journal-title":"Thromb Haemost"},{"issue":"3","key":"1829_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.amjms.2020.10.025","volume":"361","author":"WH Chong","year":"2021","unstructured":"Chong WH, Saha BK (2021) Relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the etiology of acute kidney injury (AKI). Am J Med Sci 361(3):287\u2013296. https:\/\/doi.org\/10.1016\/j.amjms.2020.10.025","journal-title":"Am J Med Sci"},{"key":"1829_CR39","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1016\/j.csbj.2020.09.019","volume":"18","author":"R Chowdhury","year":"2020","unstructured":"Chowdhury R, Boorla VS, Maranas CD (2020) Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity. Comput Struct Biotechnol J 18:2573\u20132582. https:\/\/doi.org\/10.1016\/j.csbj.2020.09.019","journal-title":"Comput Struct Biotechnol J"},{"key":"1829_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13437","author":"C Conforti","year":"2020","unstructured":"Conforti C et al (2020) Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.13437","journal-title":"Dermatol Ther"},{"key":"1829_CR206","unstructured":"Coronavirus N (2020) World Health Organization"},{"key":"1829_CR41","doi-asserted-by":"publisher","first-page":"eAO6739","DOI":"10.31744\/einstein_journal\/2021AO6739","volume":"19","author":"TD Corr\u00eaa","year":"2021","unstructured":"Corr\u00eaa TD, Midega TD, Timenetsky KT, Cordioli RL, Barbas CSV, Silva J\u00fanior M, Bravim BDA, Silva BC, Matos GFJD, Nawa RK, Carvalho FRTD (2021) Clinical characteristics and outcomes of COVID-19 patients admitted to the intensive care unit during the first year of the pandemic in Brazil: a single center retrospective cohort study. Einstein (Sao Paulo) 19:eAO6739","journal-title":"Einstein (Sao Paulo)"},{"issue":"6891","key":"1829_CR42","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA et al (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417(6891):822\u2013828. https:\/\/doi.org\/10.1038\/nature00786","journal-title":"Nature"},{"issue":"6","key":"1829_CR43","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui S et al (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemostasis 18(6):1421\u20131424. https:\/\/doi.org\/10.1111\/jth.14830","journal-title":"J Thromb Haemostasis"},{"issue":"11","key":"1829_CR44","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1128\/CVI.05034-11","volume":"18","author":"RS Davies","year":"2011","unstructured":"Davies RS et al (2011) Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum. Clin Vacc Immunol 18(11):1962\u20131968. https:\/\/doi.org\/10.1128\/CVI.05034-11","journal-title":"Clin Vacc Immunol"},{"issue":"2","key":"1829_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1160\/TH12-06-0425","volume":"109","author":"OJ de Boer","year":"2013","unstructured":"de Boer OJ et al (2013) Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemostasis 109(2):290\u2013297. https:\/\/doi.org\/10.1160\/TH12-06-0425","journal-title":"Thromb Haemostasis"},{"issue":"3","key":"1829_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1164\/ajrccm.165.3.2104099","volume":"165","author":"W De Mony\u00e9","year":"2002","unstructured":"De Mony\u00e9 W et al (2002) Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 165(3):345\u2013348. https:\/\/doi.org\/10.1164\/ajrccm.165.3.2104099","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1829_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","volume":"14","author":"M Delamaire","year":"1997","unstructured":"Delamaire M et al (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14(1):29\u201334. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199701)14:1%3c29::AID-DIA300%3e3.0.CO;2-V","journal-title":"Diabet Med"},{"key":"1829_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijcard.2020.03.087","volume":"311","author":"Q Deng","year":"2020","unstructured":"Deng Q et al (2020) Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol 311:116\u2013121. https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.087","journal-title":"Int J Cardiol"},{"issue":"6","key":"1829_CR49","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","volume":"64","author":"MR Deshotels","year":"2014","unstructured":"Deshotels MR et al (2014) Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension (Dallas, Tex: 1979) 64(6):1368\u20131375. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03743","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"4","key":"1829_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/bf00200608","volume":"97","author":"G Drasch","year":"1986","unstructured":"Drasch G, Eisenmenger W (1986) Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda. J Leg Med 97(4):285\u2013293. https:\/\/doi.org\/10.1007\/bf00200608","journal-title":"J Leg Med"},{"issue":"5","key":"1829_CR51","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/ATVBAHA.120.315595","volume":"41","author":"A Dupont","year":"2021","unstructured":"Dupont A et al (2021) Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler Thromb Vasc Biol 41(5):1760\u20131773. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315595","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1829_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jhep.2015.07.041","volume":"64","author":"JK Dyson","year":"2016","unstructured":"Dyson JK et al (2016) Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use. J Hepatol 64(1):234\u2013238. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.041","journal-title":"J Hepatol"},{"issue":"5","key":"1829_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.37358\/RC.20.5.8159","volume":"71","author":"K Earar","year":"2020","unstructured":"Earar K et al (2020) Biochemical effects and therapeutic application of vitamin C (C6H8O6) on COVID-19 infection. Rev Chim 71(5):473\u2013478","journal-title":"Rev Chim"},{"issue":"2","key":"1829_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2020.1813024","volume":"19","author":"D Echeverr\u00eda-Esnal","year":"2021","unstructured":"Echeverr\u00eda-Esnal D et al (2021) Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti-Infect Ther 19(2):147\u2013163. https:\/\/doi.org\/10.1080\/14787210.2020.1813024","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"5","key":"1829_CR55","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","volume":"71","author":"S Eguchi","year":"2018","unstructured":"Eguchi S et al (2018) Understanding angiotensin II Type 1 receptor signaling in vascular pathophysiology. Hypertension (Dallas, Tex: 1979) 71(5):804\u2013810. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.10266","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"2","key":"1829_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1128\/IAI.66.2.486-491.1998","volume":"66","author":"E Elass-Rochard","year":"1998","unstructured":"Elass-Rochard E et al (1998) Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun 66(2):486\u2013491. https:\/\/doi.org\/10.1128\/IAI.66.2.486-491.1998","journal-title":"Infect Immun"},{"issue":"3","key":"1829_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.25122\/jml-2021-0175","volume":"15","author":"MA-S Elgohary","year":"2022","unstructured":"Elgohary MA-S et al (2022) Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial. J Med Life 15(3):350\u2013358. https:\/\/doi.org\/10.25122\/jml-2021-0175","journal-title":"J Med Life"},{"issue":"6","key":"1829_CR58","doi-asserted-by":"publisher","first-page":"e0130248","DOI":"10.1371\/journal.pone.0130248","volume":"10","author":"Y Enoki","year":"2015","unstructured":"Enoki Y et al (2015) Pleiotropic effects of levofloxacin, fluoroquinolone antibiotics, against influenza virus-induced lung injury. PLoS ONE 10(6):e0130248. https:\/\/doi.org\/10.1371\/journal.pone.0130248","journal-title":"PLoS ONE"},{"issue":"7","key":"1829_CR59","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","volume":"18","author":"Z Fan","year":"2020","unstructured":"Fan Z et al (2020) Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol 18(7):1561\u20131566. https:\/\/doi.org\/10.1016\/j.cgh.2020.04.002","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1829_CR60","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/CCM.0b013e31825332fc","volume":"40","author":"L Fern\u00e1ndez-Barat","year":"2012","unstructured":"Fern\u00e1ndez-Barat L et al (2012) Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes. Crit Care Med 40(8):2385\u20132389. https:\/\/doi.org\/10.1097\/CCM.0b013e31825332fc","journal-title":"Crit Care Med"},{"key":"1829_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1432","author":"RE Ferner","year":"2020","unstructured":"Ferner RE, Aronson JK (2020) Chloroquine and hydroxychloroquine in covid-19. BMJ (Clin Res Ed). https:\/\/doi.org\/10.1136\/bmj.m1432","journal-title":"BMJ (Clin Res Ed)"},{"issue":"7","key":"1829_CR62","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Y Furuta","year":"2017","unstructured":"Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B 93(7):449\u2013463. https:\/\/doi.org\/10.2183\/pjab.93.027","journal-title":"Proc Jpn Acad Ser B"},{"key":"1829_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jcp.33.Suppl_14.10","volume":"14","author":"PJ Gaffney","year":"1980","unstructured":"Gaffney PJ (1980) Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications. J Clin Pathol Suppl (r Coll Pathol) 14:10\u201317","journal-title":"J Clin Pathol Suppl (r Coll Pathol)"},{"issue":"2","key":"1829_CR64","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1006\/viro.2000.0757","volume":"279","author":"TM Gallagher","year":"2001","unstructured":"Gallagher TM, Buchmeier MJ (2001) Coronavirus spike proteins in viral entry and pathogenesis. Virology 279(2):371\u2013374. https:\/\/doi.org\/10.1006\/viro.2000.0757","journal-title":"Virology"},{"issue":"5","key":"1829_CR65","doi-asserted-by":"publisher","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","volume":"295","author":"PE Gallagher","year":"2008","unstructured":"Gallagher PE, Ferrario CM, Tallant EA (2008) MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol 295(5):C1169\u2013C1174. https:\/\/doi.org\/10.1152\/ajpcell.00145.2008","journal-title":"Am J Physiol"},{"issue":"10","key":"1829_CR66","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M et al (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 Receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 126(10):1456\u20131474. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317015","journal-title":"Circ Res"},{"key":"1829_CR67","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3389\/fimmu.2020.01409","volume":"11","author":"V Gies","year":"2020","unstructured":"Gies V et al (2020) Beyond anti-viral effects of chloroquine\/hydroxychloroquine. Front Immunol 11:1409. https:\/\/doi.org\/10.3389\/fimmu.2020.01409","journal-title":"Front Immunol"},{"issue":"3","key":"1829_CR69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.47102\/annals-acadmedsg.202057","volume":"49","author":"KJ Goh","year":"2020","unstructured":"Goh KJ et al (2020) Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from coronavirus disease 2019 (COVID-19) infection. Ann Acad Med Singap 49(3):108\u2013118","journal-title":"Ann Acad Med Singap"},{"issue":"19","key":"1829_CR70","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","volume":"383","author":"JD Goldman","year":"2020","unstructured":"Goldman JD et al (2020) Remdesivir for 5 or 10 days in patients with severe COVID-19. N Engl J Med 383(19):1827\u20131837. https:\/\/doi.org\/10.1056\/NEJMoa2015301","journal-title":"N Engl J Med"},{"issue":"4","key":"1829_CR71","doi-asserted-by":"publisher","first-page":"301.e1","DOI":"10.1016\/j.ijantimicag.2008.07.020","volume":"33","author":"SA Gonz\u00e1lez-Ch\u00e1vez","year":"2009","unstructured":"Gonz\u00e1lez-Ch\u00e1vez SA, Sigifredo Ar\u00e9valo-Gallegos QR-C (2009) Lactoferrin: structure, function and applications. Int J Antimicrob Agents 33(4):301.e1\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.07.020","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"1829_CR72","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni A et al (2020) Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181(7):1489\u20131501","journal-title":"Cell"},{"issue":"1","key":"1829_CR73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11239-014-1101-6","volume":"39","author":"R Halaby","year":"2015","unstructured":"Halaby R et al (2015) D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis 39(1):55\u201359. https:\/\/doi.org\/10.1007\/s11239-014-1101-6","journal-title":"J Thromb Thrombolysis"},{"issue":"46","key":"1829_CR74","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.3748\/wjg.v26.i46.7272","volume":"26","author":"AS Hanafy","year":"2020","unstructured":"Hanafy AS, Abd-Elsalam S (2020) Challenges in COVID-19 drug treatment in patients with advanced liver diseases: a hepatology perspective. World J Gastroenterol 26(46):7272\u20137286. https:\/\/doi.org\/10.3748\/wjg.v26.i46.7272","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1829_CR76","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/14787210.2021.1866545","volume":"19","author":"SM Hashemian","year":"2021","unstructured":"Hashemian SM, Farhadi T, Velayati AA (2021) A review on favipiravir: the properties, function, and usefulness to treat COVID-19. Expert Rev Anti-Infect Ther 19(8):1029\u20131037. https:\/\/doi.org\/10.1080\/14787210.2021.1866545","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"23","key":"1829_CR77","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","volume":"141","author":"NS Hendren","year":"2020","unstructured":"Hendren NS et al (2020) Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 141(23):1903\u20131914. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047349","journal-title":"Circulation"},{"issue":"7","key":"1829_CR78","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/emboj.2013.53","volume":"32","author":"MW Hentze","year":"2013","unstructured":"Hentze MW, Preiss T (2013) Circular RNAs: splicing\u2019s enigma variations. EMBO J 32(7):923\u2013925. https:\/\/doi.org\/10.1038\/emboj.2013.53","journal-title":"EMBO J"},{"issue":"5","key":"1829_CR79","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","volume":"52","author":"T Hirano","year":"2020","unstructured":"Hirano T, Murakami M (2020) COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(5):731\u2013733. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.003","journal-title":"Immunity"},{"issue":"3","key":"1829_CR80","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3947\/ic.2020.52.3.317","volume":"52","author":"T Hoang","year":"2020","unstructured":"Hoang T, Anh TTT (2020) Treatment options for severe acute respiratory syndrome, middle east respiratory syndrome, and coronavirus disease 2019: a review of clinical evidence. Infect Chemother 52(3):317","journal-title":"Infect Chemother"},{"issue":"2","key":"1829_CR81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"Suppl 2","key":"1829_CR82","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2165\/00003495-199958002-00002","volume":"58","author":"DC Hooper","year":"1999","unstructured":"Hooper DC (1999) Mode of action of fluoroquinolones. Drugs 58(Suppl 2):6\u201310. https:\/\/doi.org\/10.2165\/00003495-199958002-00002","journal-title":"Drugs"},{"issue":"5091","key":"1829_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (NY) 259(5091):87\u201391. https:\/\/doi.org\/10.1126\/science.7678183","journal-title":"Science (NY)"},{"key":"1829_CR84","doi-asserted-by":"crossref","unstructured":"Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, ..., RECOVERY Collaborative Group (2020) Effect of dexamethasone in hospitalized patients with COVID-19\u2013preliminary report. MedRxiv, 2020-06","DOI":"10.1101\/2020.06.22.20137273"},{"issue":"4","key":"1829_CR85","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.15190\/d.2020.18","volume":"8","author":"MS Hossain","year":"2020","unstructured":"Hossain MS, Hami I, Sawrav MSS, Rabbi MF, Saha O, Bahadur NM, Rahaman MM (2020) Drug repurposing for prevention and treatment of COVID-19: a clinical landscape. Discoveries 8(4):e121","journal-title":"Discoveries"},{"issue":"1","key":"1829_CR86","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250\u2013256","journal-title":"J Med Virol"},{"issue":"10223","key":"1829_CR87","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Lond, Engl) 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet (Lond, Engl)"},{"issue":"10","key":"1829_CR88","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1182\/blood.V99.10.3637","volume":"99","author":"D Huber","year":"2002","unstructured":"Huber D et al (2002) Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo. Blood 99(10):3637\u20133645","journal-title":"Blood"},{"issue":"7","key":"1829_CR89","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1073\/pnas.1809667116","volume":"116","author":"RJG Hulswit","year":"2019","unstructured":"Hulswit RJG et al (2019) Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc Natl Acad Sci USA 116(7):2681\u20132690. https:\/\/doi.org\/10.1073\/pnas.1809667116","journal-title":"Proc Natl Acad Sci USA"},{"key":"1829_CR90","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fphar.2020.01169","volume":"11","author":"JP Hussman","year":"2020","unstructured":"Hussman JP (2020) Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention. Front Pharmacol 11:1169","journal-title":"Front Pharmacol"},{"issue":"7047","key":"1829_CR91","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y et al (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112\u2013116. https:\/\/doi.org\/10.1038\/nature03712","journal-title":"Nature"},{"key":"1829_CR92","doi-asserted-by":"publisher","first-page":"118102","DOI":"10.1016\/j.lfs.2020.118102","volume":"257","author":"A Jafarzadeh","year":"2020","unstructured":"Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M (2020) Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life sciences 257:118102","journal-title":"Life sciences"},{"issue":"23","key":"1829_CR93","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","volume":"79","author":"HP Jia","year":"2005","unstructured":"Jia HP et al (2005) ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79(23):14614\u201314621. https:\/\/doi.org\/10.1128\/JVI.79.23.14614-14621.2005","journal-title":"J Virol"},{"issue":"7","key":"1829_CR94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","volume":"11","author":"F Jiang","year":"2014","unstructured":"Jiang F et al (2014) Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets. Nat Rev 11(7):413\u2013426. https:\/\/doi.org\/10.1038\/nrcardio.2014.59","journal-title":"Nat Rev"},{"key":"1829_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101665","author":"P Karami","year":"2020","unstructured":"Karami P et al (2020) WITHDRAWN: mortality of a pregnant patient diagnosed with COVID-19: a case report with clinical, radiological, and histopathological findings. Travel Med Infect Dis. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101665","journal-title":"Travel Med Infect Dis"},{"issue":"7","key":"1829_CR96","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.arcmed.2020.06.004","volume":"51","author":"I Karampela","year":"2020","unstructured":"Karampela I, Dalamaga M (2020) Could respiratory fluoroquinolones, levofloxacin and moxifloxacin, prove to be beneficial as an adjunct treatment in COVID-19? Arch Med Res 51(7):741\u2013742. https:\/\/doi.org\/10.1016\/j.arcmed.2020.06.004","journal-title":"Arch Med Res"},{"issue":"6","key":"1829_CR99","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548\u20132556. https:\/\/doi.org\/10.1210\/jc.2004-0395","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1829_CR100","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/jcph.1693","volume":"60","author":"S Khiali","year":"2020","unstructured":"Khiali S, Khani E, Entezari-Maleki T (2020) A comprehensive review of tocilizumab in COVID-19 acute respiratory distress syndrome. J Clin Pharmacol 60(9):1131\u20131146. https:\/\/doi.org\/10.1002\/jcph.1693","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"1829_CR205","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/14712598.2021.1847269","volume":"21","author":"S Khiali","year":"2021","unstructured":"Khiali S, Rezagholizadeh A, Entezari-Maleki T (2021) A comprehensive review on sarilumab in COVID-19. Expert Opin Biol Ther 21(5):615\u2013626","journal-title":"Expert Opin Biol Ther"},{"key":"1829_CR101","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"issue":"4","key":"1829_CR102","doi-asserted-by":"publisher","first-page":"CD012645","DOI":"10.1002\/14651858.CD012645","volume":"4","author":"O Komolafe","year":"2017","unstructured":"Komolafe O et al (2017) Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis. Cochrane Database Syst Rev 4(4):CD012645. https:\/\/doi.org\/10.1002\/14651858.CD012645","journal-title":"Cochrane Database Syst Rev"},{"key":"1829_CR103","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131774","author":"KA Kulcsar","year":"2019","unstructured":"Kulcsar KA et al (2019) Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.131774","journal-title":"JCI Insight"},{"key":"1829_CR104","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jpeds.2016.02.071","volume":"173","author":"D Legrand","year":"2016","unstructured":"Legrand D (2016) Overview of lactoferrin as a natural immune modulator. J Pediatr 173:S10\u2013S15. https:\/\/doi.org\/10.1016\/j.jpeds.2016.02.071","journal-title":"J Pediatr"},{"key":"1829_CR105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coph.2015.07.002","volume":"24","author":"VJC Lempers","year":"2015","unstructured":"Lempers VJC et al (2015) Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice. Curr Opin Pharmacol 24:38\u201344. https:\/\/doi.org\/10.1016\/j.coph.2015.07.002","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"1829_CR106","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","volume":"93","author":"RA Lew","year":"2008","unstructured":"Lew RA et al (2008) Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp Physiol 93(5):685\u2013693. https:\/\/doi.org\/10.1113\/expphysiol.2007.040352","journal-title":"Exp Physiol"},{"issue":"1","key":"1829_CR107","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 3(1):237\u2013261. https:\/\/doi.org\/10.1146\/annurev-virology-110615-042301","journal-title":"Annu Rev Virol"},{"issue":"20","key":"1829_CR108","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.4103\/0366-6999.243559","volume":"131","author":"Z-Z Li","year":"2018","unstructured":"Li Z-Z et al (2018) Unfractionated heparin with sequential enoxaparin in patients with complex coronary artery lesions during percutaneous coronary intervention. Chin Med J 131(20):2417\u20132423. https:\/\/doi.org\/10.4103\/0366-6999.243559","journal-title":"Chin Med J"},{"issue":"9","key":"1829_CR109","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/ijms21093097","volume":"21","author":"LF Li","year":"2020","unstructured":"Li LF, Liu YY, Lin SW, Chang CH, Chen NH, Hung CY, Lee CS (2020) Low-molecular-weight heparin reduces ventilation-induced lung injury through hypoxia inducible factor-1\u03b1 in a murine endotoxemia model. Int J Mol Sci 21(9):3097","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1829_CR111","doi-asserted-by":"publisher","first-page":"ofaa500","DOI":"10.1093\/ofid\/ofaa500","volume":"7","author":"SM Lofgren","year":"2020","unstructured":"Lofgren SM et al (2020) Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19. Open Forum Infect Dis 7(11):ofaa500. https:\/\/doi.org\/10.1093\/ofid\/ofaa500","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"1829_CR113","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","volume":"5","author":"M Madjid","year":"2020","unstructured":"Madjid M et al (2020) Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 5(7):831\u2013840. https:\/\/doi.org\/10.1001\/jamacardio.2020.1286","journal-title":"JAMA Cardiol"},{"key":"1829_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 220:1\u201313. https:\/\/doi.org\/10.1016\/j.trsl.2020.04.007","journal-title":"Transl Res"},{"issue":"5","key":"1829_CR115","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jjcc.2020.07.013","volume":"76","author":"F Mai","year":"2020","unstructured":"Mai F, Del Pinto R, Ferri C (2020) COVID-19 and cardiovascular diseases. J Cardiol 76(5):453\u2013458. https:\/\/doi.org\/10.1016\/j.jjcc.2020.07.013","journal-title":"J Cardiol"},{"issue":"6","key":"1829_CR116","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s43440-020-00169-0","volume":"72","author":"K Marciniec","year":"2020","unstructured":"Marciniec K et al (2020) Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis. Pharmacol Rep 72(6):1553\u20131561. https:\/\/doi.org\/10.1007\/s43440-020-00169-0","journal-title":"Pharmacol Rep"},{"issue":"12","key":"1829_CR117","doi-asserted-by":"publisher","first-page":"H1585","DOI":"10.1152\/ajpheart.00096.2013","volume":"304","author":"FA Martin","year":"2013","unstructured":"Martin FA, Murphy RP, Cummins PM (2013) Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol-Heart Circ Physiol 304(12):H1585\u2013H1597","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"13","key":"1829_CR118","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S et al (2020) Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci USA 117(13):7001\u20137003. https:\/\/doi.org\/10.1073\/pnas.2002589117","journal-title":"Proc Natl Acad Sci USA"},{"key":"1829_CR119","doi-asserted-by":"publisher","first-page":"813358","DOI":"10.3389\/fmicb.2022.813358","volume":"13","author":"J Mehta","year":"2022","unstructured":"Mehta J, Rolta R, Mehta BB, Kaushik N, Choi EH, Kaushik NK (2022) Role of dexamethasone and methylprednisolone corticosteroids in coronavirus disease 2019 hospitalized patients: a review. Front Microbiol 13:813358","journal-title":"Front Microbiol"},{"issue":"6","key":"1829_CR120","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355\u2013362","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1829_CR121","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","volume":"5","author":"NJ Mercuro","year":"2020","unstructured":"Mercuro NJ et al (2020) Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(9):1036\u20131041. https:\/\/doi.org\/10.1001\/jamacardio.2020.1834","journal-title":"JAMA Cardiol"},{"issue":"4","key":"1829_CR122","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V et al (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181(4):905-913.e7. https:\/\/doi.org\/10.1016\/j.cell.2020.04.004","journal-title":"Cell"},{"issue":"9","key":"1829_CR123","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1172\/JCI656","volume":"101","author":"M Morigi","year":"1998","unstructured":"Morigi M et al (1998) Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Investig 101(9):1905\u20131915. https:\/\/doi.org\/10.1172\/JCI656","journal-title":"J Clin Investig"},{"issue":"4","key":"1829_CR124","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"M Murakami","year":"2019","unstructured":"Murakami M, Kamimura D, Hirano T (2019) Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity 50(4):812\u2013831. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.027","journal-title":"Immunity"},{"issue":"6","key":"1829_CR125","doi-asserted-by":"publisher","first-page":"H2000","DOI":"10.1152\/ajpheart.1996.270.6.H2000","volume":"270","author":"D Negrini","year":"1996","unstructured":"Negrini D et al (1996) Pulmonary interstitial pressure and proteoglycans during development of pulmonary Edema. Am J Physiol-Heart Circ Physiol 270(6):H2000\u2013H2007","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"2","key":"1829_CR126","doi-asserted-by":"publisher","first-page":"L203","DOI":"10.1152\/ajplung.1998.274.2.L203","volume":"274","author":"D Negrini","year":"1998","unstructured":"Negrini D et al (1998) Proteoglycan involvement during development of lesional pulmonary edema. Am J Physiol 274(2):L203\u2013L211. https:\/\/doi.org\/10.1152\/ajplung.1998.274.2.L203","journal-title":"Am J Physiol"},{"issue":"4","key":"1829_CR127","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s00134-007-0962-y","volume":"34","author":"D Negrini","year":"2008","unstructured":"Negrini D, Passi A, Moriondo A (2008) The role of proteoglycans in pulmonary edema development. Intensive Care Med 34(4):610\u2013618. https:\/\/doi.org\/10.1007\/s00134-007-0962-y","journal-title":"Intensive Care Med"},{"issue":"6","key":"1829_CR128","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","volume":"73","author":"E Niel","year":"2006","unstructured":"Niel E, Scherrmann J-M (2006) Colchicine today. Jt Bone Spine 73(6):672\u2013678. https:\/\/doi.org\/10.1016\/j.jbspin.2006.03.006","journal-title":"Jt Bone Spine"},{"issue":"9","key":"1829_CR129","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga M et al (2020) COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17(9):543\u2013558. https:\/\/doi.org\/10.1038\/s41569-020-0413-9","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"1829_CR130","doi-asserted-by":"publisher","first-page":"e97784","DOI":"10.1371\/journal.pone.0097784","volume":"9","author":"A Obermayer","year":"2014","unstructured":"Obermayer A et al (2014) New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation. PLoS ONE 9(5):e97784. https:\/\/doi.org\/10.1371\/journal.pone.0097784","journal-title":"PLoS ONE"},{"issue":"12","key":"1829_CR131","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/01.ATV.0000189309.05924.88","volume":"25","author":"JJ Oliver","year":"2005","unstructured":"Oliver JJ, Webb DJ, Newby DE (2005) Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 25(12):2470\u20132479","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1829_CR132","doi-asserted-by":"publisher","first-page":"e13382","DOI":"10.1111\/eci.13382","volume":"50","author":"J Olloquequi","year":"2020","unstructured":"Olloquequi J (2020) COVID-19 susceptibility in chronic obstructive pulmonary disease. Eur J Clin Investig 50(10):e13382. https:\/\/doi.org\/10.1111\/eci.13382","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"1829_CR133","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11(1):1620. https:\/\/doi.org\/10.1038\/s41467-020-15562-9","journal-title":"Nat Commun"},{"issue":"7","key":"1829_CR134","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","volume":"39","author":"GY Oudit","year":"2009","unstructured":"Oudit GY et al (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Investig 39(7):618\u2013625. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02153.x","journal-title":"Eur J Clin Investig"},{"key":"1829_CR135","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmac021","author":"S Pal","year":"2022","unstructured":"Pal S et al (2022) Effect of antenatal dexamethasone in late preterm period on neonatal hypoglycemia: a prospective cohort study from a developing country. J Trop Pediatr. https:\/\/doi.org\/10.1093\/tropej\/fmac021","journal-title":"J Trop Pediatr"},{"issue":"2","key":"1829_CR136","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.13091","volume":"288","author":"G Pascarella","year":"2020","unstructured":"Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agr\u00f2 FE (2020) COVID-19 diagnosis and management: a comprehensive review. J Intern Med 288(2):192\u2013206","journal-title":"J Intern Med"},{"issue":"3","key":"1829_CR137","doi-asserted-by":"publisher","first-page":"L631","DOI":"10.1152\/ajplung.1998.275.3.L631","volume":"275","author":"A Passi","year":"1998","unstructured":"Passi A et al (1998) Involvement of lung interstitial proteoglycans in development of hydraulic-and elastase-induced Edema. Am J Physiol-Lung Cell Mol Physiol 275(3):L631\u2013L635","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"8","key":"1829_CR138","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB et al (2016) Role of the ACE2\/Angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure. Circ Res 118(8):1313\u20131326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307708","journal-title":"Circ Res"},{"issue":"5","key":"1829_CR139","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000507305","volume":"144","author":"L Perico","year":"2020","unstructured":"Perico L, Benigni A, Remuzzi G (2020) Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron 144(5):213\u2013221. https:\/\/doi.org\/10.1159\/000507305","journal-title":"Nephron"},{"issue":"2","key":"1829_CR140","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3324\/haematol.2016.142471","volume":"102","author":"S Pfeiler","year":"2017","unstructured":"Pfeiler S et al (2017) Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica 102(2):206\u2013213. https:\/\/doi.org\/10.3324\/haematol.2016.142471","journal-title":"Haematologica"},{"issue":"6","key":"1829_CR141","first-page":"41","volume":"18","author":"AL Plumb","year":"2004","unstructured":"Plumb AL (2004) Drugs. com: drug information online 2004. Ref Rev 18(6):41","journal-title":"Ref Rev"},{"issue":"6","key":"1829_CR142","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.thromres.2014.03.036","volume":"133","author":"TK Pon","year":"2014","unstructured":"Pon TK et al (2014) Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients. Thromb Res 133(6):1023\u20131028. https:\/\/doi.org\/10.1016\/j.thromres.2014.03.036","journal-title":"Thromb Res"},{"issue":"1","key":"1829_CR143","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","volume":"24","author":"S Pons","year":"2020","unstructured":"Pons S et al (2020) The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care (Lond, Engl) 24(1):353. https:\/\/doi.org\/10.1186\/s13054-020-03062-7","journal-title":"Crit Care (Lond, Engl)"},{"issue":"1","key":"1829_CR144","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1038\/s41598-018-21901-0","volume":"8","author":"M Pourfathi","year":"2018","unstructured":"Pourfathi M et al (2018) Lung metabolism and inflammation during mechanical ventilation; an imaging approach. Sci Rep 8(1):3525. https:\/\/doi.org\/10.1038\/s41598-018-21901-0","journal-title":"Sci Rep"},{"issue":"2","key":"1829_CR145","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1189\/jlb.1106688","volume":"82","author":"P Puddu","year":"2007","unstructured":"Puddu P et al (2007) Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. J Leukoc Biol 82(2):347\u2013353. https:\/\/doi.org\/10.1189\/jlb.1106688","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1829_CR146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biochi.2008.05.005","volume":"91","author":"P Puddu","year":"2009","unstructured":"Puddu P, Valenti P, Gessani S (2009) Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 91(1):11\u201318","journal-title":"Biochimie"},{"key":"1829_CR147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2011400","author":"VG Puelles","year":"2020","unstructured":"Puelles VG et al (2020) Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2011400","journal-title":"N Engl J Med"},{"issue":"1","key":"1829_CR148","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.chest.2020.04.024","volume":"158","author":"J Radbel","year":"2020","unstructured":"Radbel J, Narayanan N, Bhatt PJ (2020) Use of tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report. Chest 158(1):e15\u2013e19. https:\/\/doi.org\/10.1016\/j.chest.2020.04.024","journal-title":"Chest"},{"issue":"6","key":"1829_CR149","doi-asserted-by":"publisher","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand J et al (2018) Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS ONE 13(6):e0198144. https:\/\/doi.org\/10.1371\/journal.pone.0198144","journal-title":"PLoS ONE"},{"issue":"6881","key":"1829_CR150","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/bmj.306.6881.841","volume":"306","author":"DC Rees","year":"1993","unstructured":"Rees DC, Kelsey H, Richards JD (1993) Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ (Clin Res Ed) 306(6881):841\u2013842. https:\/\/doi.org\/10.1136\/bmj.306.6881.841","journal-title":"BMJ (Clin Res Ed)"},{"issue":"1","key":"1829_CR151","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12933-020-01035-2","volume":"19","author":"H Ren","year":"2020","unstructured":"Ren H et al (2020) Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc Diabetol 19(1):58. https:\/\/doi.org\/10.1186\/s12933-020-01035-2","journal-title":"Cardiovasc Diabetol"},{"key":"1829_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094941","author":"M Riou","year":"2024","unstructured":"Riou M et al (2024) Mechanisms of pulmonary vasculopathy in acute and long-term COVID-19: a review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25094941","journal-title":"Int J Mol Sci"},{"key":"1829_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31094-1","author":"S Riphagen","year":"2020","unstructured":"Riphagen S et al (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet (Lond, Engl). https:\/\/doi.org\/10.1016\/S0140-6736(20)31094-1","journal-title":"Lancet (Lond, Engl)"},{"key":"1829_CR154","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2020.1778470","author":"C Robba","year":"2020","unstructured":"Robba C et al (2020) Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. https:\/\/doi.org\/10.1080\/17476348.2020.1778470","journal-title":"Expert Rev Respir Med"},{"issue":"12","key":"1829_CR155","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1586\/14787210.2013.855126","volume":"11","author":"M Rodr\u00edguez-Torres","year":"2013","unstructured":"Rodr\u00edguez-Torres M (2013) Sofosbuvir (GS-7977), a pan-genotype, direct-acting antiviral for hepatitis C virus infection. Expert Rev Anti-Infect Ther 11(12):1269\u20131279. https:\/\/doi.org\/10.1586\/14787210.2013.855126","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"3","key":"1829_CR156","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1086\/318486","volume":"32","author":"E Rubinstein","year":"2001","unstructured":"Rubinstein E et al (2001) Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 32(3):402\u2013412. https:\/\/doi.org\/10.1086\/318486","journal-title":"Clin Infect Dis"},{"key":"1829_CR157","doi-asserted-by":"publisher","first-page":"108296","DOI":"10.1016\/j.diabres.2020.108296","volume":"166","author":"LJ Sacks","year":"2020","unstructured":"Sacks LJ et al (2020) Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic. Diabetes Res Clin Pract 166:108296. https:\/\/doi.org\/10.1016\/j.diabres.2020.108296","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1829_CR158","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","volume":"15","author":"C Salata","year":"2017","unstructured":"Salata C et al (2017) Antiviral activity of cationic amphiphilic drugs. Expert Rev Anti-Infect Ther 15(5):483\u2013492. https:\/\/doi.org\/10.1080\/14787210.2017.1305888","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1829_CR161","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jcm9051417","volume":"4","author":"C Sardu","year":"2020","unstructured":"Sardu C et al (2020) Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease\u202f? A comprehensive evaluation of clinical and basic evidence. J Clin Med 4:5. https:\/\/doi.org\/10.3390\/jcm9051417","journal-title":"J Clin Med"},{"issue":"2","key":"1829_CR162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s15010-005-8202-2","volume":"33","author":"K-J Schaper","year":"2005","unstructured":"Schaper K-J, Schubert S, Dalhoff A (2005) Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens. Infection 33(2):3\u201314. https:\/\/doi.org\/10.1007\/s15010-005-8202-2","journal-title":"Infection"},{"issue":"7","key":"1829_CR163","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/2050640620931657","volume":"8","author":"JM Schattenberg","year":"2020","unstructured":"Schattenberg JM et al (2020) Patterns of liver injury in COVID-19 - a German case series. United Eur Gastroenterol J 8(7):814\u2013819. https:\/\/doi.org\/10.1177\/2050640620931657","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"1829_CR207","first-page":"737","volume":"14","author":"DK Shanmuganathan","year":"2025","unstructured":"Shanmuganathan DK, Sudesh S, Bejone SJ, Giri MD (2025) Teratogenicity of tetracyclines. World J Pharm Res 14(6):737\u2013749","journal-title":"World J Pharm Res"},{"issue":"11","key":"1829_CR164","doi-asserted-by":"publisher","first-page":"e0242400","DOI":"10.1371\/journal.pone.0242400","volume":"15","author":"M Sharifpour","year":"2020","unstructured":"Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM, Jabaley CS, Emory COVID-19 Quality & Clinical Research Collaborative (2020) C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PloS one 15(11):e0242400","journal-title":"PloS one"},{"key":"1829_CR165","doi-asserted-by":"publisher","first-page":"106714","DOI":"10.1016\/j.rmed.2021.106714","volume":"191","author":"D Sheikh","year":"2022","unstructured":"Sheikh D, Tripathi N, Chandler TR, Furmanek S, Bordon J, Ramirez JA, Cavallazzi R (2022) Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non-SARS-CoV-2 community-acquired pneumonia. Respir Med 191:106714","journal-title":"Respir Med"},{"issue":"6","key":"1829_CR166","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/cts.12880","volume":"13","author":"C Shi","year":"2020","unstructured":"Shi C et al (2020) The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study. Clin Transl Sci 13(6):1087\u20131095. https:\/\/doi.org\/10.1111\/cts.12880","journal-title":"Clin Transl Sci"},{"key":"1829_CR167","first-page":"3","volume":"1","author":"A Singh","year":"2021","unstructured":"Singh A (2021) A review of coronavirus disease-2019. BR Nahata Smriti Sansthan Int J Phramaceut Sci Clin Res 1:3","journal-title":"BR Nahata Smriti Sansthan Int J Phramaceut Sci Clin Res"},{"issue":"13","key":"1829_CR168","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.3390\/ijms22137082","volume":"22","author":"I Smarz-Widelska","year":"2021","unstructured":"Smarz-Widelska I, Grywalska E, Morawska I, Forma A, Michalski A, Mertowski S, Hrynkiewicz R, Nied\u017awiedzka-Rystwej P, Korona-Glowniak I, Parczewski M, Za\u0142uska W (2021) Pathophysiology and clinical manifestations of COVID-19-related acute kidney injury\u2014the current state of knowledge and future perspectives. Int J Mol Sci 22(13):7082","journal-title":"Int J Mol Sci"},{"key":"1829_CR169","doi-asserted-by":"publisher","DOI":"10.35543\/osf.io\/cq8sa","author":"JS Soar","year":"2020","unstructured":"Soar JS (2020) A cost-effective preventative approach to potentially save lives in the coronavirus pandemic, jointly using Vitamin D, Curcumin, and Vitamin C, (with updated dosage parameters). Bakare, T A, a and Soar JSB. Nutr Diet. https:\/\/doi.org\/10.35543\/osf.io\/cq8sa","journal-title":"Nutr Diet"},{"issue":"2","key":"1829_CR170","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","volume":"30","author":"A Soro-Paavonen","year":"2012","unstructured":"Soro-Paavonen A et al (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 30(2):375\u2013383. https:\/\/doi.org\/10.1097\/HJH.0b013e32834f04b6","journal-title":"J Hypertens"},{"key":"1829_CR171","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047525","author":"GG Stefanini","year":"2020","unstructured":"Stefanini GG et al (2020) ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047525","journal-title":"Circulation"},{"issue":"5","key":"1829_CR172","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26(5):681\u2013687. https:\/\/doi.org\/10.1038\/s41591-020-0868-6","journal-title":"Nat Med"},{"key":"1829_CR173","doi-asserted-by":"crossref","unstructured":"Talukdar D, Jain V, Balaramnavar V, Srivastava SP, Sivanandy P, Gupta MM (2021) Potential drugs for COVID-19 treatment management with their contraindications and drug-drug interaction","DOI":"10.20944\/preprints202105.0690.v1"},{"issue":"5","key":"1829_CR174","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"issue":"43","key":"1829_CR175","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR et al (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43):33238\u201333243. https:\/\/doi.org\/10.1074\/jbc.M002615200","journal-title":"J Biol Chem"},{"issue":"6","key":"1829_CR176","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"MA Tortorici","year":"2019","unstructured":"Tortorici MA et al (2019) Structural basis for human coronavirus attachment to sialic acid receptors. Nat Struct Mol Biol 26(6):481\u2013489. https:\/\/doi.org\/10.1038\/s41594-019-0233-y","journal-title":"Nat Struct Mol Biol"},{"issue":"17","key":"1829_CR177","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M et al (2020) Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19. N Engl J Med 382(17):1653\u20131659. https:\/\/doi.org\/10.1056\/NEJMsr2005760","journal-title":"N Engl J Med"},{"issue":"1","key":"1829_CR178","doi-asserted-by":"publisher","first-page":"1731942","DOI":"10.1080\/2162402X.2020.1731942","volume":"9","author":"S Van Wilpe","year":"2020","unstructured":"Van Wilpe S et al (2020) Lactate dehydrogenase: a marker of diminished antitumor immunity. Oncoimmunology 9(1):1731942. https:\/\/doi.org\/10.1080\/2162402X.2020.1731942","journal-title":"Oncoimmunology"},{"key":"1829_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","author":"Z Varga","year":"2020","unstructured":"Varga Z et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet (Lond, Engl). https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet (Lond, Engl)"},{"key":"1829_CR181","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ et al (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69. https:\/\/doi.org\/10.1186\/1743-422X-2-69","journal-title":"Virol J"},{"issue":"6","key":"1829_CR182","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1161\/ATVBAHA.118.310367","volume":"38","author":"M Wang","year":"2018","unstructured":"Wang M et al (2018) Thrombotic regulation from the endothelial cell perspectives. Arterioscler Thromb Vasc Biol 38(6):e90\u2013e95. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310367","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1829_CR183","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/10408398.2017.1381583","volume":"59","author":"B Wang","year":"2019","unstructured":"Wang B et al (2019) Lactoferrin: structure, function, denaturation and digestion. Crit Rev Food Sci Nutr 59(4):580\u2013596. https:\/\/doi.org\/10.1080\/10408398.2017.1381583","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"11","key":"1829_CR185","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D et al (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"issue":"6","key":"1829_CR186","doi-asserted-by":"publisher","first-page":"105948","DOI":"10.1016\/j.ijantimicag.2020.105948","volume":"55","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020b) Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents 55(6):105948. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105948","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"1829_CR187","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3892\/etm.2020.9402","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y et al (2020c) Lactoferrin for the treatment of COVID-19 (Review). Exp Ther Med 20(6):272. https:\/\/doi.org\/10.3892\/etm.2020.9402","journal-title":"Exp Ther Med"},{"issue":"7","key":"1829_CR184","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.18632\/aging.103000","volume":"12","author":"B Wang","year":"2020","unstructured":"Wang B et al (2020d) Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 12(7):6049","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"1829_CR188","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40261-014-0238-6","volume":"34","author":"S Wason","year":"2014","unstructured":"Wason S, Mount D, Faulkner R (2014) Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease. Clin Drug Investig 34(12):845\u2013855. https:\/\/doi.org\/10.1007\/s40261-014-0238-6","journal-title":"Clin Drug Investig"},{"issue":"7821","key":"1829_CR189","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821):430\u2013436. https:\/\/doi.org\/10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"issue":"19","key":"1829_CR190","doi-asserted-by":"publisher","first-page":"504","DOI":"10.21037\/atm.2019.09.28","volume":"7","author":"JJM Wong","year":"2019","unstructured":"Wong JJM et al (2019) Insights into the immuno-pathogenesis of acute respiratory distress syndrome. Ann Transl Med 7(19):504","journal-title":"Ann Transl Med"},{"issue":"6483","key":"1829_CR191","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York) 367(6483):1260\u20131263. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Science (New York)"},{"key":"1829_CR192","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.niox.2020.06.002","volume":"102","author":"J Wu","year":"2020","unstructured":"Wu J (2020) Tackle the free radicals damage in COVID-19. Nitric Oxide 102:39\u201341. https:\/\/doi.org\/10.1016\/j.niox.2020.06.002","journal-title":"Nitric Oxide"},{"issue":"1","key":"1829_CR193","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s13054-020-03340-4","volume":"24","author":"C Wu","year":"2020","unstructured":"Wu C et al (2020) Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis. Crit Care (Lond, Engl) 24(1):643. https:\/\/doi.org\/10.1186\/s13054-020-03340-4","journal-title":"Crit Care (Lond, Engl)"},{"issue":"6","key":"1829_CR194","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","volume":"158","author":"F Xiao","year":"2020","unstructured":"Xiao F et al (2020) Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158(6):1831\u20131833. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.055","journal-title":"Gastroenterology"},{"issue":"1","key":"1829_CR195","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu H et al (2020a) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):8. https:\/\/doi.org\/10.1038\/s41368-020-0074-x","journal-title":"Int J Oral Sci"},{"issue":"4","key":"1829_CR196","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z et al (2020b) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420\u2013422","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1829_CR197","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet 8(5):475\u2013481. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet"},{"issue":"2","key":"1829_CR198","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","volume":"142","author":"L Zhang","year":"2020","unstructured":"Zhang L et al (2020a) Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation 142(2):114\u2013128. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046702","journal-title":"Circulation"},{"key":"1829_CR199","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020b) Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2007575","journal-title":"N Engl J Med"},{"issue":"8","key":"1829_CR200","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/dom.14086","volume":"22","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020c) The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: a single-centre, retrospective, observational study in Wuhan. Diabetes Obes Metab 22(8):1443\u20131454. https:\/\/doi.org\/10.1111\/dom.14086","journal-title":"Diabetes Obes Metab"},{"key":"1829_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100165","author":"L Zhao","year":"2021","unstructured":"Zhao L, Zhong W (2021) Mechanism of action of favipiravir against SARS-CoV-2: mutagenesis or chain termination? Innovation [cambridge (Mass)]. https:\/\/doi.org\/10.1016\/j.xinn.2021.100165","journal-title":"Innovation [cambridge (Mass)]"},{"issue":"10229","key":"1829_CR202","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F et al (2020a) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet (London, England)"},{"issue":"7798","key":"1829_CR203","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P et al (2020b) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"issue":"6","key":"1829_CR204","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu L et al (2020) Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 31(6):1068\u20131077. https:\/\/doi.org\/10.1016\/j.cmet.2020.04.021","journal-title":"Cell Metab"},{"issue":"5","key":"1829_CR208","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrd.2015.37","volume":"15","author":"A Zumla","year":"2016","unstructured":"Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY (2016) Coronaviruses\u2014drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327\u2013347","journal-title":"Nat Rev Drug Discov"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:14:40Z","timestamp":1758082480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":199,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01829-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No delaration of interest is to be declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}